Evaluation of the Efficacy of a Polynucleotide-Based Preparation in the Treatment of Androgenetic Alopecia

The study evaluated a polynucleotide-based intradermal gel for treating androgenetic alopecia in 60 participants over three months. Participants received 8 scalp injections, and the treatment's effectiveness was assessed using the Global Aesthetic Improvement Scale. Results showed subjective improvement in all cases, with no deterioration observed. Only one mild adverse event, injection-site erythema, was reported. The usability of the treatment was rated as "good" in all cases. The findings support the use of this polynucleotide-based gel for androgenetic alopecia, confirming its favorable safety profile and potential for broader patient application.